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http://dx.doi.org/10.1016/j.pedneo.2NiemannePick type C (NPC; OMIM 257219) disease is a neurodegenerative lysosomal storage
disorder characterized by accumulation of unesterified cholesterol in the lysosomal/late en-
dosomal system. This autosomal recessive disorder occurs in approximately 1/150,000
births. The broad clinical spectrum ranges from a prenatal severe presentation to an
adult-onset chronic neurodegenerative disease. Data about prenatal presentation of NPC
are limited. A female newborn was born at 342 weeks’ gestation with a birth weight of
3070 g, and transferred to the Neonatal Intensive Care Unit because of nonimmune hydrops
fetalis (NIHF) and respiratory distress. On admission, a physical examination revealed skin
edema, mild respiratory distress, and abdominal distention due to massive ascites. Hepatos-
plenomegaly and cholestasis increased progressively and bleeding diathesis occurred. Re-
sults of an abdominal ultrasonography showed hepatosplenomegaly and segmental
multicystic dysplastic left kidney. Foamy cells with a lysosomal phospholipid storage pattern
compatible with NPC were found in the bone marrow smear. Cultured fibroblasts showed
a strongly elevated filipin staining (classical NPC cellular phenotype), establishing the diag-
nosis of NPC. The infant died on the 52nd day of life because of respiratory distress due toy Unit, Hacettepe University Ihsan Dogramaci Children’s Hospital, Ankara, Turkey.
l.com (O. Surmeli-Onay).
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NiemannePick type C 345lung involvement of NPC, massive ascites, and progressive liver failure. Results of an autopsy
showed multiorgan storage disease involving the liver, spleen, lymph nodes, thymus, lungs,
and brain. Here, we present a preterm infant with NIHF as a sign of severe prenatal-onset
NPC and review the literature.
Copyright ª 2013, Taiwan Pediatric Association. Published by Elsevier Taiwan LLC. All rights
reserved.1. Introduction
NiemannePick type C (NPC; OMIM 257219) disease is
a neurodegenerative lysosomal storage disorder (LSD),
which is characterized by the accumulation of unesterified
cholesterol in the lysosomal/late endosomal system.1,2 This
autosomal recessive disorder occurs in approximately
1/150,000 births.3 Mutations in the NPC1 and NPC2 genes
are responsible for the anomaly of intracellular transport of
low-density lipoprotein-cholesterol. Disrupted cellular Ca2þ
signaling has been reported in the pathogenesis of LSD. A
previous study has shown that defective lysosomal Ca2þ
uptake and defective nicotinic acid adenine dinucleotide
phosphate-mediated lysosomal Ca2þ release causes dis-
ruption in endocytosis and lipid storage.4 The broad clinical
spectrum ranges from a prenatal severe presentation to an
adult-onset chronic neurodegenerative disease.5,6 Neuro-
logical signs are useful for distinguishing several clinical
forms: delay in developmental motor milestones in the
early infantile form (2 monthse2 years), gait problems,
falls, clumsiness, cataplexy, school problems in the late
infantile (2e6 years) and juvenile form (6e15 years) (clas-
sical form), and ataxia not infrequently following initial
psychiatric disturbances in the adult form (>15 years). The
most characteristic sign is vertical supranuclear gaze palsy.
In 40% of cases, the disease occurs during the neonatal
period. Neonates present with prolonged cholestatic jaun-
dice, which usually disappears toward the age of 2e4
months, but this may also progress to fatal liver failure.7
The prenatal presentation of NPC has been described pre-
viously in detail in only a few case reports.
First, Maconochie et al reported two cases with NPC
initially presenting with fetal ascites at 18 and 33 weeks of
gestation. These patients were born prematurely with
pronounced hepatosplenomegaly and ascites.8 Later,
Manning et al reported a similar case of a patient with NPC
who presented with polyhydramnios and fetal ascites at 26
weeks of gestation.9 He was also a preterm infant with
massive ascites and hepatosplenomegaly. Two of these
three patients died within the 1st month of life due to
rapidly progressive liver failure.
Here, we present a preterm infant presenting with
nonimmune hydrops fetalis (NIHF) as a sign of prenatal-
onset NPC and review the literature pertaining to this
condition.2. Case Report
A female newborn was born to a gravida 3, para 1 30-year-
old mother by cesarean section at 342 weeks’ gestationwith a birth weight of 3070 g and an Apgar score of 7/8/8 in
the 1st, 5th, and 10th minute, respectively. The baby was
transferred to the Neonatal Intensive Care Unit because of
NIHF and respiratory distress. The parents were not con-
sanguineous. A detailed obstetric ultrasonography at the
27th week of gestation showed hydrops fetalis, fetal asci-
tes, and polyhydramnios. The blood group of the mother
was an Rh positive. The results of further work-up,
including fetal echocardiography and maternal serology
for herpes, rubella, cytomegalovirus, toxoplasma, and
parvoviruses were normal.
On admission, a physical examination of the newborn
revealed skin edema, tachypnea, mild respiratory distress,
and abdominal distention due to ascites. Initially, she had
no dysmorphic features or organomegaly and her weight
and height were at the 90th percentile. The results of the
initial hematologic tests revealed thrombocytopenia (pla-
telet count: 47  109/L) and diagnostic paracentesis
revealed a transudate fluid.
Hepatosplenomegaly and cholestasis appeared gradually
and the coagulation parameters worsened at the end of the
1st week. Ursodeoxycholic acid and spironolactone were
administered in addition to fresh-frozen plasma transfusion
and vitamin K. Results of an abdominal ultrasonography
showed hepatosplenomegaly and a segmental multicystic
left kidney. The blood and urinary levels of amino acids and
organic acids were normal. Serum chitotriosidase activity
and lysosomal enzyme screening were also normal. Foamy
cells with a lysosomal phospholipid storage pattern com-
patible with NPC were found in the bone marrow smear
(Figure 1). The results of filipin testing in cultivated fibro-
blasts were highly elevated, establishing the diagnosis of
NPC. Molecular genetic analysis revealed that the infant was
compound heterozygous for the deletion of p.D611_E612del
(c.1831_1836delGATGAA) in exon 12 and for the deletion
p.P1245fs (c.3734_3735delCT) in exon 24 of the NPC1 gene.
The infant died on her 52nd day of life because of respiratory
distress due to lung involvement of NPC, together with
massive ascites and progressive liver failure. Written
informed consent was obtained from parents.
A pathologic examination of the placenta revealed pla-
centomegaly [1100 g (N: 389 g)], villous edema, and focal
infarct. In the liver, there were vacuolated hepatocytes
with pseudoglandular transformation and rare multi-
nucleated giant cells. Portal fibrosis and intralobular-
perisinusoidal fibrosis were noticed. There were numerous
foamy storage cells within the hepatic sinusoids, portal
tracts, and splenic sinuses (Figure 2). In the lungs, the
alveoli contained many foamy storage cells. The upper pole
of the left kidney was multicystic and there was a double
collecting system on that side. The upper ureter was
Figure 1 Bone marrow smear of the patient showing foamy
cells (arrow) with a lysosomal phospholipid storage pattern
compatible with NiemannePick type C.
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microscopic examination was performed, which revealed
segmental dysplasia of the upper pole of the left kidney.
There were firm and pale-white areas in the periventricular
white matter of the frontal and occipital lobes of the brain,
where foamy storage cells and reactive astrocytosis were
demonstrated. These findings were highly suggestive of NPC
disease, which was confirmed by positive filipin staining in
cultured skin fibroblasts and later with molecular study.
3. Discussion
NIHF results from a vast array of underlying pathologies
including chromosomal anomalies, intrauterine infections,Figure 2 Clusters of foamy cells (arrow) and extramedullary
hematopoiesis present in the patient’s spleen.congenital heart disease, fetal arrhythmias, hereditary
anemias, and lymphatic diseases. In large retrospective
series, the relative frequency of the LSDs in the context of
NIHF or ascites was 1.4%.10 The LSDs related to NIHF consist
of type 2 Gaucher disease, sialidosis type II, gal-
actosialidosis, Salla disease, mucopolysaccharidosis types
IV and VII, GM1 gangliosidosis, inclusion-cell disease, NPA
and NPC, Wolman disease, and Farber disease.11 The pre-
natal onset of NPC disease is exceptionally reported in as-
sociation with NIHF.8,12
Data on the prenatal onset of NPC disease are limited.
Spiegel et al reported seven cases that were diagnosed as
fetal-onset NPC. The fetal clinical findings of NPC consisted
of in utero splenomegaly (6/7), hepatomegaly (5/7), asci-
tes (4/7), intrauterine growth restriction (2/7), and oligo-
hydramnios (2/7).13 Three patients were delivered
preterm. Postnatally, the most common clinical findings
were congenital thrombocytopenia (4/4), anemia (2/4),
and petechial rash (2/5). The authors noted a poor outcome
in both prenatal and postnatal periods with deaths occur-
ring within the first months of life due to rapidly progressing
fatal liver failure. As found in these reported cases, our
patient was born with fetal ascites after a preterm delivery
and hepatosplenomegaly developed within the 1st week of
life. Congenital thrombocytopenia was the accompanying
comorbidity and progressive liver failure was the main
cause of mortality. In addition, the infant had segmental
multicystic dysplastic left kidney due to double collecting
system, which had not previously been reported in associ-
ation with NPC. There are no data about renal malforma-
tion seen together with NPC. In summary, the results of the
molecular analyses together with a classical filipin signal
and a typical clinical presentation confirmed the diagnosis
of NPC disease in our patient. In addition, this is the first
reported case in our country, the diagnosis of whom was
confirmed with the collaboration of filipin staining, au-
topsy, and molecular genetic analysis. Neither of the de-
letions has previously been described, but both are very
likely disease causing: the deletion p.P1245fs leads to
a frameshift while the deletion of p.D611_E612del likely
affects the protein structure.
Placental findings could be cautionary for the diag-
nosis of LSD, including placentomegaly and foamy cells in
the villous stroma.13 Similarly, the placental findings
of our patient revealed placentomegaly but there were
no histopathologic features for LSDs. In addition, the
autopsy of our patient showed multiorgan storage disease
involving the liver, spleen, lungs, and brain. Moreno et al
reported two siblings with prenatal-onset NPC and the
autopsy revealed multiorgan storage disease including
the spleen, liver, lymph nodes, thymus, lungs, adrenals,
and brain.3
In conclusion, our case, in common with the previous
cases, showed that antenatal presentation of NPC disease is
most often correlated with a severe and rapidly progressing
fatal form of the disease that is histopathologically
accompanied by multisystemic involvement. Despite
promising treatments with N-butyl-deoxynojirimycin14 and
miglustat,15 to date there has been no curative treatment
for NPC. Therefore, identification of index case is essential
for genetic counseling and antenatal diagnosis.
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